Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

- Frustration over limited time spent with patients. - Inordinate amounts of time inputting required data. - Side effects including high levels of stress. The patient? Herself. The remedy? “I did the research and found direct primary care,” said Anderson-Elder of Windsor. And in June she joined Dr. Frank Morgan at Balance Health in Greeley, a direct primary care clinic he founded four years ago in Greeley. Leaving her family practice at UCHealth Medical Clinic in Windsor after seven years wasn’t an easy decision, she said, but it was the right decision for her. Many physicians — from all specialties — share Anderson-Elder’s frustration and levels of stress incurred while working in insurance-based health care systems. In the 2018 Medscape National Physician and Depression Report, 42 percent of family physicians admitted to having burnout or depression, listing “too many bureaucratic tasks (charting, paperwork)” and “too many hours at work” as the leading factors in burnout. Although direct primary care has been around for some time, it is just now gaining a toehold with both physicians contemplating the switch to a different way of providing care and patients willing to give it a shot, so to speak. In 2017, there were more than 600 direct primary care clinics in the U.S., 10 percent of those in Colorado, according to the Colorado Independent. Anderson-Elder said in her research she found 1,000 out of the 80,000 family doctors practicing in the U.S. have gone the direct primary care route. DIRECT PRIMARY CARE What is direct primary care? And why the interest? First and foremost, the major difference is that direct primary care does not accept insurance. Patients instead pay a monthly membership fee that includes unlimited visits, calls and emails, along with many routine services and access to prescriptions and lab work at a reduced cost. For the physician, it means quality time spent with patients and no more time filling out paperwork to satisfy health insurance company regulations. What the monthly fee is varies from clinic to clinic. At Balance Health, it is $99 for adults, $180 for couples and $30 for children. Those who sign up for direct primary care are asked to sign an annual contract but can be released from it with 30 days’ notice, Anderson-Elder said. “We want to be accessible to our patients. We don’t want them to go to urgent care or ER if they don’t have to,” she said. And yes, that includes calls at 3 a.m., but if it can wait till morning, the patient is worked into that day’s schedule. Anderson-Elder typically sees eight to 17 patients per day, depending on whether it’s cold and flu season. And she spends as much time as needed with them. At her previous practice, she was limited to spending 15 to 20 minutes per patient. “People service their cars,” she said. “They should do the same thing with their bodies. You should be looked at and tuned up.” While most people think of going to the doctor only when they don’t feel well or need a physical for work or school, Anderson-Elder said she likes to see patients even when they feel healthy so she can check in on their well-being and talk about proper nutrition. “Oftentimes patients think they’re healthy, but then we do an exam and sometimes find things,” she said. Direct primary care works best when combined with a high-deductible health plan, Anderson-Elder said, for those times when unexpected surgeries are scheduled and for patients who suffer from chronic illnesses. But she said about one-third of her patients have no health insurance at all. She also noted direct primary care should not be confused with concierge medicine, which also provides direct access to providers for a flat fee but still bills insurance companies for services provided. Another key distinction between the two is direct primary care is mentioned in the Affordable Care Act as an acceptable option for receiving medical care without insurance, while concierge medicine is not, according to the American Academy of Family Physicians. And last year, Colorado Gov. John Hickenlooper signed Colorado HB17-1115, which establishes that direct primary health care can operate without regulation of the division of insurance. Windsor Republican Rep. Perry Buck was a primary sponsor of the bill. Patients at Balance Health also can tap into other healthy-living services for additional fees. Dr. Dana Morgan, a family care physician, specializes in bioidentical hormone replacement therapy. Balance Health also has a small fitness gym replete with trainers and classes. Wellness coaching also is offered. Leaving her practice in Windsor, though a hard decision, has been the right prescription for her, she said. “I no longer take paperwork home,” she said. “I’m happier and less stressed.” ___ Information from: The Tribune of Greeley, Co, http://greeleytribune.com
Windsor doctor joining direct primary care movement.

The Kate Spade New York Foundation said in a statement Wednesday it is donating $200,000 to The Jed Foundation, which partners with schools to strengthen mental health programs. The fashion brand will match public donations to JED from Wednesday through June 12, up to $100,000, at jedfoundation.org/katespade. The donations follow money already given to other organizations, including the Crisis Text Line. Anna Bakst, brand president and CEO of Kate Spade New York, said the company hopes to encourage more conversation, education and research around mental health. Spade killed herself June 5, 2018, at 55, after years of battling depression and anxiety.
Kate Spade New York fulfills $1 million mental health pledge.

"While no price has been set, this story still confronts cost by pointing out that other biotech drugs cost thousands of dollars per month of treatment. The story included key details about the difference in survival rates and length between the treatment and control arms of the trial. The story gives both the median survival length and the three-year survival figures for participants in the treatment and placebo arms of the trial. It might have been helpful to say ""half the men survived at least"" rather than ""median survival was."" The story lists the serious side effects reported in the trial and the fact that earlier trials raised worries about strokes related to treatment. Although this story, like the USA Today report that we reviewed, stated in the lead that patients receiving Provenge lived four months longer without specifying that it was four months longer than placebo, not standard therapy, it does a better job of detailing the available results. The story improperly compares the reported survival advantage of the experimental treatment to the expected survival of men receiving standard chemotherapy, implying the two treatments have been tested head-to-head. The story also includes speculation that Provenge could be more effective when given earlier in the course of the disease, even though there is no evidence to support the statement. Quotes at the end of the story from leaders of some patient advocacy groups overstated the evidence of effectiveness, but they seem to accurately reflect the perspective of these activists. The story didn’t discuss the condition of advanced prostate cancer in detail, so this is N/A. The story includes comments from independent experts. It notes that the drug developer paid for the study and that the lead researcher owns company stock. In addition, the story notes how the company stock price was fluctuating; a good reminder that research reports can have substantial financial consequences. The story did not refer to the stock price jump earlier this month that followed the vague company announcement at a meeting with analysts claiming that the treatment extended patient survival. The story mentions that chemotherapy with Taxotere is the only approved treatment for patients with advanced prostate cancer. It should not have stated that Provenge produces a greater survival benefit, since the treatments have not been directly compared. The story points out that Provenge has not been approved by the FDA. The story reported that Provenge is the first therapeutic cancer vaccine ""to meet a preset goal for improving survival in late-stage testing."" The story included original reporting. However, one comment from a spokesman for the American Urological Association appears to have been taken from a news release without specifying that it was contained in a statement, rather than in an interview."

Study: Prostate cancer vaccine extends survival

